The pharmaceutical industry has been facing unprecedented challenges, over the past few years. Even though hubs of innovation and advanced solutions have been widely shaping business processes, pharma companies are struggling to bring new drugs to market due to pricing pressures caused by healthcare reforms and increased competition.
February 2017| View Digital Version
Michele C. D’Alessandro, VP & CIO, Manufacturing IT, Merck & Co., Inc.
Leo Barella, VP, Enterprise Architecture, Astrazeneca
Kevin Dawson, VP, Information Services, LA BioMed Los Angeles Biomedical Research Institute
Brad Martin, Senior Director, Product Marketing, PRO Unlimited
Michael Murphy, Chief Medical and Scientific Officer, Worldwide Clinical Trials
Silji Abraham, VP & CIO, MilliporeSigma
Kali Durgampudi, VP of Innovation and Mobility, Nuance Communications
Ajay Shah, Director, Research Informatics and Systems Division, City of Hope
Chris Johns, CIO, PNC Asset Management Group and PNC Investments
New architectures of databases and new IT infrastructures enable the biotech companies to overcome
The ability to process large amounts of data from different sources and extract the relevant
The biotech industry has experienced a rapid expansion of data in the recent years. Biotech
July - August 2016
In todays data-driven era, sophisticated technology tools are bringing data and people together to
From inception to completion of a trial life cycle, data managers are implementing Clinical Data
The Clinical Data Management (CDM) process, like any clinical trial, begins with the end in mind.
Pharmaceutical companies are traditionally known for their commercial models–an army of sales reps